[company_age]13.0[/company_age][employees]2-10 employees[/employees][funding]Series A[/funding][description]Samabriva Biotechnology is a French company that has developed a novel method for producing biopharmaceuticals, chemicals, and biotech products using plants. Their unique approach combines the benefits of plant-based systems with traditional biomanufacturing techniques, enabling the efficient production of high-value products. Samabriva's technology utilizes large-scale bioreactors to cultivate high-yield plant clones, resulting in a more sustainable and cost-effective alternative to traditional manufacturing methods. The company specializes in the production of complex recombinant proteins, natural active molecules (secondary metabolites), and VLPs for the biopharmaceuticals and API markets. Their innovative hairy root culture offers several advantages, including a controlled supply chain, year-round continuous production, and freedom from animal-based products, viruses, and prions. Samabriva's technology has the potential to revolutionize the biomanufacturing industry by providing a more efficient, sustainable, and cost-effective way to produce high-value products.[/description][ps]Biopharmaceuticals, chemicals, and biotech products using plants[/ps]